Medlab Clinical Limited (MDC.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 12:59PM AEDT
| Previous close | 6.60 |
| Open | 6.60 |
| Bid | 0.00 x 3519200 |
| Ask | 0.00 x 165200 |
| Day's range | 6.60 - 6.60 |
| 52-week range | 6.55 - 11.79 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 15.071M |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
MEDLAB ANNOUNCES FAVOURABLE INTERIM READOUT OF NANABIS™ REAL-WORLD EVIDENCE (RWE) MEDCARE STUDY
N=1,172 Australian pain patientsDatapoints collected from commencing NanaBis™ (baseline) up to month 1255% improvement in pain relief75% of patients reduced their opioid use31% Improvements in Quality of Life as it relates to pain interference92% of patients with bone metastasis from cancer had reduced their pain severity and pain interference (Quality of Life) scores at 6-monthsNew “ENHANCE” study expects to onboard March 2023 Sydney, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Medlab Clinical Ltd (ASX:M
© 2023 Yahoo. All rights reserved.
